In the high-stakes world of biopharmaceutical development, timing, precision, and regulatory alignment often determine whether a program advances or stalls. For AEON Biopharma Inc. (AEON), the final stretch of 2025 is shaping up to be a pivotal chapter, one that could either validate years of groundwork or demand a strategic reset.
A Critical Meeting on the Horizon
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.